Episode 325 - Dr. Viral Shah, Professor of Medicine of Endocrinology Indiana University

In this episode of the Diabetes Innovators Series, Rob interviews Dr. Viral
N Shah discussing the Adjust T1D trial, which investigates the effects of
semaglutide, a GLP-1 agonist, on adults with type 1 diabetes. The trial
aims to explore adjunctive treatment options beyond insulin, focusing on
improving glycemic control, weight loss, and overall patient outcomes. Dr.
Shah shares insights on the trial's design, results, safety profile, and
implications for future diabetes management, emphasizing the need for
continued research and community support.

Chapters

00:00 Introduction to the Adjust T1D Trial

03:06 Understanding Type 1 Diabetes and Treatment Options

05:46 Results of the Adjust T1D Trial

08:54 Safety and Efficacy of Semaglutide

11:45 Implications for Type 1 Diabetes Management

14:52 Future Research and Community Impact

Resources:

Dr. Viral Shah